The Rally Continued For Cassava Sciences (SAVA), Up 43% Pre-Market
The biotechnology company, Cassava Sciences Inc. (SAVA), a developer of drugs for nervous system disorders, has been seeing its stock price rising 43.83% in early trades floating at $126.50 (07:12 a.m. EST). The rise could be attributed to results announced by the company on Tuesday of an interim analysis from an open-label study of the […]
